Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults
Open Access
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Mechanisms of Action of AdjuvantsFrontiers in Immunology, 2013
- Abrogation of nontypeable Haemophilus influenzae Protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitis mediaVaccine, 2011
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell ResponsesJournal of Clinical Immunology, 2010
- InvasiveHaemophilus influenzaeDisease, Europe, 1996–2006Emerging Infectious Diseases, 2010
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- Immunosenescence: what does it mean to health outcomes in older adults?Current Opinion in Immunology, 2009
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Antimicrobial Resistance inHaemophilus influenzaeClinical Microbiology Reviews, 2007
- The Changing Epidemiology of Invasive Haemophilus influenzae Disease, Especially in Persons >=65 Years OldClinical Infectious Diseases, 2007
- Effects of cigarette smoke on the immune systemNature Reviews Immunology, 2002